Cardiac Biomarkers Testing Global Market Report 2024

Description

“Cardiac Biomarkers Testing Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiac biomarkers testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiac biomarkers testing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The cardiac biomarkers testing market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Biomarkers Type: Creatine Kinase (CK-MB); Troponins; Myoglobin; Natriuretic Peptides (BNP and NT-proBNP); Ischemia Modified albumin (IMA); Other Biomarkers Types
2) By Application: Congestive Heart Failure; Acute Coronary Syndrome; Myocardial Infarction; Atherosclerosis; Other Applications
3) By End-User: Hospitals; Specialty Clinics
Companies Mentioned: Abbott Laboratories; Bio-Rad Laboratories Inc.; Danaher Corporation; F. Hoffmann-La Roche Ltd.; Siemens Healthineers AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Cardiac biomarkers testing involves assessing the levels of specific substances in the blood, aiding in the diagnosis, evaluation, and monitoring of individuals possibly experiencing acute coronary syndrome (ACS).

Key biomarkers in cardiac biomarkers testing include creatine kinase (CK-MB), troponins, myoglobin, natriuretic peptides (BNP and NT-proBNP), ischemia-modified albumin (IMA), and various others. Creatine kinase (CK-MB) is an enzyme analyzed through a blood test. These tests find applications in conditions such as congestive heart failure, acute coronary syndrome, myocardial infarction, atherosclerosis, among others, primarily utilized by hospitals and specialized clinics.

The cardiac biomarkers testing market research report is one of a series of new reports from The Business Research Company that provides cardiac biomarkers testing market statistics, including cardiac biomarkers testing industry global market size, regional shares, competitors with cardiac biomarkers testing market share, detailed cardiac biomarkers testing market segments, market trends, and opportunities, and any further data you may need to thrive in the cardiac biomarkers testing industry. This cardiac biomarkers testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cardiac biomarkers testing market size has grown rapidly in recent years. It will grow from $12.15 billion in 2023 to $13.63 billion in 2024 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period of cardiac biomarkers testing can be attributed to various factors including a rise in cardiovascular diseases, an aging population, increased awareness through educational initiatives, supportive government policies, and a general uptick in healthcare expenditure. These elements collectively contributed to the expansion and adoption of cardiac biomarker tests.

The cardiac biomarkers testing market size is expected to see rapid growth in the next few years. It will grow to $21.31 billion in 2028 at a compound annual growth rate (CAGR) of 11.8%. In the forthcoming period, the growth of cardiac biomarkers testing is expected due to the emergence of personalized medicine, a worldwide increase in cardiovascular diseases, the incorporation of artificial intelligence (AI) into diagnostics, the widening scope of point-of-care testing (POCT), and a greater focus on early disease detection. Key trends anticipated in this period encompass technological advancements, the evolution of AI-assisted diagnostics, the expansion of point-of-care testing (POCT), the enhancement of multiplexing capabilities, and ongoing efforts in biomarker discovery and validation.

The anticipated rise in the prevalence of cardiovascular diseases is poised to drive the growth of the cardiac biomarkers testing market. Cardiovascular diseases, impacting the heart or blood vessels, necessitate quick and accurate diagnostic tools. Cardiac biomarker tests play a crucial role by assessing biomarker levels to promptly determine the severity and magnitude of a heart attack. As indicated by data from the American College of Cardiology in August 2022, the United States is expected to witness a considerable increase in the rates of cardiovascular risk factors and diseases by the year 2060. This projection underscores the anticipated surge in demand for cardiac biomarker testing solutions, aligning with the overall growth of the cardiac biomarkers testing market.

The growing demand for personalized medical solutions emerges as a significant driver propelling the cardiac biomarkers testing market forward. Personalized medicine, tailoring medical decisions and interventions to individual patients, is increasingly incorporating cardiac biomarkers testing for more precise cardiovascular care. This integration enhances prevention, early detection, and treatment strategies, addressing the specific needs of each patient. Notably, reports from October 2022 indicate a significant presence of over 75,000 genetic testing products and 300 personalized medicines, reflecting the expanding demand for personalized medicine solutions. This trend contributes to the sustained growth of the cardiac biomarkers testing market.

Product innovations stand out as a key trend within the cardiac biomarkers testing market, with major companies prioritizing the development of innovative solutions to maintain their market positions. Siemens Healthcare GmbH, a Germany-based medical technology company, exemplified this trend in October 2021 with the launch of the Atellica VTLi Patient-Side Immunoassay Analyzer. Distinguished by its high-sensitivity troponin I test from a fingerstick sample, this analyzer enables clinicians and healthcare professionals to diagnose a heart attack rapidly and reliably in just eight minutes. The introduction of such innovative products underscores the industry's commitment to advancing diagnostic capabilities and improving patient outcomes in the cardiac biomarkers testing market.

Prominent companies in the cardiac biomarker testing market are strategically focusing on innovative products, with a particular emphasis on cardiac biomarkers, to drive revenue growth. Cardiac biomarkers, also referred to as cardiac enzymes, are substances released into the bloodstream in response to heart muscle damage, serving as crucial indicators in diagnosing and monitoring cardiovascular conditions. In October 2023, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., a China-based company specializing in medical equipment and solutions, launched troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. The hs-cTn assay surpasses minimal requirements for sensitivity, accuracy, and reliability in identifying myocardial damage. These innovative products aim to enhance treatment for cardiovascular illnesses, providing reliable solutions that improve patient outcomes both within and beyond the realm of cardiovascular diseases.

In September 2021 , Shenzhen Mindray Bio-Medical Electronics Co. Ltd executed the acquisition of HyTest Invest Oy and its subsidiaries, including HyTest Ltd, for an undisclosed amount. HyTest, a US-based provider of antibodies and antigens with a focus on the In Vitro Diagnostics (IVD) market, brings valuable expertise in cardiac indicators, inflammation, tumor markers, and other diagnostic areas. This acquisition enhances Mindray's research and development (R&D) capabilities for raw materials, reinforcing its commitment to innovation. It positions HyTest to maintain its status as a world leader in the upstream IVD raw material industry by supporting continued investment in R&D and strengthening its core competitive edge. The strategic acquisition aligns with the industry trend of enhancing capabilities and expanding product portfolios to meet evolving demands in the cardiac biomarker testing market.

Major companies operating in the cardiac biomarkers testing market report are Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Biomerieux SA, Becton Dickinson and Company, Randox Laboratories Ltd., Enzo Biochem Inc., Creative Diagnostics Inc., Merck Co. & KGaA, Beckman Coulter Inc., QIAGEN N.V., PerkinElmer Inc., Tosoh Corporation, Eurolyser Diagnostica GmbH, Cortez Diagnostics Inc., DIALAB GmbH, CardioGenics Holdings Inc., Lepu Medical Technology (Beijing) Co. Ltd., Biosynex SA, Charles River Laboratories, Quidel Corporation, Life Diagnostics, Trinity Biotech plc, Guangzhou Wondfo Biotech Co. Ltd., Nova Biomedical Corp., Ortho Clinical Diagnostics Inc., Sekisui Diagnostics Inc., Abcam plc, Bio-Techne Corporation .

North America was the largest region in the cardiac biomarkers testing market in 2023. The regions covered in the cardiac biomarkers testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the cardiac biomarkers testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cardiac biomarkers testing market includes revenues earned by entities by providing ischemia-modified albumin (IMA), peptides, and C-reactive protein (CRP) biomarkers testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r10819

1. Executive Summary

2. Cardiac Biomarkers Testing Market Characteristics

3. Cardiac Biomarkers Testing Market Trends And Strategies

4. Cardiac Biomarkers Testing Market - Macro Economic Scenario

4.1. Impact Of High Inflation On the Market
4.2. Ukraine-Russia War Impact On the Market
4.3. COVID-19 Impact On the Market

5. Global Cardiac Biomarkers Testing Market Size and Growth

5.1. Global Cardiac Biomarkers Testing Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Cardiac Biomarkers Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Cardiac Biomarkers Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cardiac Biomarkers Testing Market Segmentation

6.1. Global Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Creatine Kinase (CK-MB)
Troponins
Myoglobin
Natriuretic Peptides (BNP and NT-proBNP)
Ischemia Modified albumin (IMA)
Other Biomarkers Types
6.2. Global Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Congestive Heart Failure
Acute Coronary Syndrome
Myocardial Infarction
Atherosclerosis
Other Applications
6.3. Global Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Specialty Clinics

7. Cardiac Biomarkers Testing Market Regional And Country Analysis

7.1. Global Cardiac Biomarkers Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Cardiac Biomarkers Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cardiac Biomarkers Testing Market

8.1. Asia-Pacific Cardiac Biomarkers Testing Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cardiac Biomarkers Testing Market

9.1. China Cardiac Biomarkers Testing Market Overview
9.2. China Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cardiac Biomarkers Testing Market

10.1. India Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cardiac Biomarkers Testing Market

11.1. Japan Cardiac Biomarkers Testing Market Overview
11.2. Japan Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cardiac Biomarkers Testing Market

12.1. Australia Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cardiac Biomarkers Testing Market

13.1. Indonesia Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cardiac Biomarkers Testing Market

14.1. South Korea Cardiac Biomarkers Testing Market Overview
14.2. South Korea Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cardiac Biomarkers Testing Market

15.1. Western Europe Cardiac Biomarkers Testing Market Overview
15.2. Western Europe Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cardiac Biomarkers Testing Market

16.1. UK Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cardiac Biomarkers Testing Market

17.1. Germany Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cardiac Biomarkers Testing Market

18.1. France Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cardiac Biomarkers Testing Market

19.1. Italy Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cardiac Biomarkers Testing Market

20.1. Spain Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cardiac Biomarkers Testing Market

21.1. Eastern Europe Cardiac Biomarkers Testing Market Overview
21.2. Eastern Europe Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cardiac Biomarkers Testing Market

22.1. Russia Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cardiac Biomarkers Testing Market

23.1. North America Cardiac Biomarkers Testing Market Overview
23.2. North America Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cardiac Biomarkers Testing Market

24.1. USA Cardiac Biomarkers Testing Market Overview
24.2. USA Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cardiac Biomarkers Testing Market

25.1. Canada Cardiac Biomarkers Testing Market Overview
25.2. Canada Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cardiac Biomarkers Testing Market

26.1. South America Cardiac Biomarkers Testing Market Overview
26.2. South America Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cardiac Biomarkers Testing Market

27.1. Brazil Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cardiac Biomarkers Testing Market

28.1. Middle East Cardiac Biomarkers Testing Market Overview
28.2. Middle East Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cardiac Biomarkers Testing Market

29.1. Africa Cardiac Biomarkers Testing Market Overview
29.2. Africa Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cardiac Biomarkers Testing Market Competitive Landscape And Company Profiles

30.1. Cardiac Biomarkers Testing Market Competitive Landscape
30.2. Cardiac Biomarkers Testing Market Company Profiles
- 30.2.1. Abbott Laboratories
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Bio-Rad Laboratories Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Danaher Corporation
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. F. Hoffmann-La Roche Ltd.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Siemens Healthineers AG
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Cardiac Biomarkers Testing Market Competitive Benchmarking

32. Global Cardiac Biomarkers Testing Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Cardiac Biomarkers Testing Market

34. Cardiac Biomarkers Testing Market Future Outlook and Potential Analysis

34.1 Cardiac Biomarkers Testing Market In 2028 - Countries Offering Most New Opportunities
34.2 Cardiac Biomarkers Testing Market In 2028 - Segments Offering Most New Opportunities
34.3 Cardiac Biomarkers Testing Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer